Sugi Predict

Sugi Predict / Compounds / SCHEMBL2910475

SCHEMBL2910475

SCHEMBL2910475

OB(O)C=Cc1ccc(-c2ccccc2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 6/20 1.00
▸ MGLL Q99685 3/20 1.00
▸ CA2 P00918 3/20 0.61
▸ HDAC2 Q92769 2/20 0.48
▸ HDAC1 Q13547 1/20 0.46
▸ HDAC6 Q9UBN7 1/20 0.46
▸ TP53 P04637 1/20 0.44
▸ MMP3 P08254 1/20 0.41
▸ BCL2L1 Q07817 1/20 0.41
▸ ARG2 P78540 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.39
▸ TRPM2 O94759 1/20 0.39
▸ LTB4R Q15722 1/20 0.39
▸ EGFR P00533 1/20 0.37
▸ GRIK1 P39086 1/20 0.37
▸ GRIK2 Q13002 1/20 0.37
▸ MAOB P27338 1/20 0.37
▸ P4HB P07237 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12260418 1.00 CA1 (1.00) CA1MGLLCA2HDAC2HDAC1
Styrylboronic Acid SCHEMBL144461 0.86 CA1 (1.00) CA1MGLLCA2HDAC2HDAC1
Styrylboronic Acid SCHEMBL4168786 0.86 CA1 (1.00) CA1MGLLCA2HDAC2HDAC1
Styrylboronic Acid SCHEMBL144460 0.86 CA1 (1.00) CA1MGLLCA2HDAC2HDAC1
Styrylboronic Acid SCHEMBL4390084 0.84 CA1 (0.95) CA1MGLLCA2HDAC2HDAC1
SCHEMBL76158 0.78 CA1 (0.62) CA1MGLLHDAC2HDAC1HDAC6
SCHEMBL9171323 0.78 CA1 (0.62) CA1MGLLHDAC2HDAC1HDAC6
SCHEMBL76159 0.78 CA1 (0.62) CA1MGLLHDAC2HDAC1HDAC6
SCHEMBL4004892 0.76 CA1 (0.60) CA1MGLLHDAC2HDAC1HDAC6
SCHEMBL11548255 0.76 CA1 (0.60) CA1MGLLHDAC2HDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110698585-A High-temperature-resistant modified acrylate pressure-sensitive adhesive and preparation method thereof 四川羽玺新材料股份有限公司 2020-01-17 — — CN claimed
US-8361484-B2 Polymer systems for lung volume reduction therapy AERIS THERAPEUTICS, INC. (US) 2013-01-29 — — US claimed
US-20100040538-A1 Polymer Systems for Lung Volume Reduction Therapy CANADIAN IMPERIAL BANK OF COMMERCE (CA) 2010-02-18 — — US claimed
EP-2059227-A2 POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY Aeris Therapeutics, Inc. (US) 2009-05-20 — — EP claimed
WO-2008039827-A2 POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY AERIS THERAPEUTICS, INC. (US) 2008-04-03 — — WO claimed
EP-4371986-B1 SUBSTITUTED PYRIDAZINONES AS HERBICIDES SYNGENTA CROP PROTECTION AG (CH) 2026-02-25 — — EP disclosed
US-12540120-B2 Herbicidal compounds SYNGENTA CROP PROTECTION AG (CH) 2026-02-03 — — US disclosed
US-20240425474-A1 VINYL THIANTHRENIUM COMPOUND, PROCESS FOR ITS PREPARATION AND ITS USE FOR TRANSFERRING A VINYL GROUP STUDIENGESELLSCHAFT KOHLE GGMBH (DE) 2024-12-26 — — US disclosed
EP-3999494-B1 SUBSTITUTED PYRIDAZINONES AS HERBICIDES SYNGENTA CROP PROTECTION AG (CH) 2024-09-11 — — EP disclosed
CN-118108674-A Substituted pyridazinones as herbicides 先正达农作物保护股份公司 2024-05-31 — — CN disclosed
CN-118084803-A Substituted pyridazinones as herbicides 先正达农作物保护股份公司 2024-05-28 — — CN disclosed
CN-118084802-A Substituted pyridazinones as herbicides 先正达农作物保护股份公司 2024-05-28 — — CN disclosed
WO-2009052341-A1 GSM INTERMEDIATES JANSSEN PHARMACEUTICA, N.V. (BE) 2009-04-23 — — WO disclosed
WO-2009052334-A1 CARBON LINKED MODULATORS OF Y-SECRETASE JANSSEN PHARMACEUTICA, N.V. (BE) 2009-04-23 — — WO disclosed
US-20090105288-A1 CARBON LINKED MODULATORS OF gamma-SECRETASE JANSSEN PHARMACEUTICA N.V. (BE) 2009-04-23 — — US disclosed
EP-2001844-A2 BICYCLIC CARBOXYLIC ACID DERIVATIVES USEFUL FOR TREATING METABOLIC DISORDERS Amgen, Inc (US) 2008-12-17 — — EP disclosed
WO-2008086404-A1 5-PYRIDINONE SUBSTITUTED INDAZOLES ALBANY MOLECULAR RESEARCH, INC. (US) 2008-07-17 — — WO disclosed
WO-2008039827-A2 POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY AERIS THERAPEUTICS, INC. (US) 2008-04-03 — — WO disclosed
US-20070244155-A1 Bicyclic carboxylic acid derivatives useful for treating metabolic disorders AMGEN INC. (US) 2007-10-18 — — US disclosed
WO-2007106469-A2 BICYCLIC CARBOXYLIC ACID DERIVATIVES USEFUL FOR TREATING METABOLIC DISORDERS AMGEN INC. (US) 2007-09-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105288-A1 CARBON LINKED MODULATORS OF gamma-SECRETASE BACE1, BACE2, PSEN1 CA1 48/4885MGLL 3003/4885CA2 1202/4885
US-20240425474-A1 VINYL THIANTHRENIUM COMPOUND, PROCESS FOR ITS PREPARATION AND ITS USE FOR TRANSFERRING A VINYL GROUP TRRAP, TST, TERB1 CA1 4853/4885MGLL 4170/4885CA2 4822/4885
US-20070244155-A1 Bicyclic carboxylic acid derivatives useful for treating metabolic disorders GOT2, PC, GOT1 CA1 703/4885MGLL 779/4885CA2 467/4885
US-20100040538-A1 Polymer Systems for Lung Volume Reduction Therapy GFER, MUC1, CTH CA1 1918/4885MGLL 2208/4885CA2 2856/4885
US-12540120-B2 Herbicidal compounds CBR3, CBR1, HACL2 CA1 1275/4885MGLL 465/4885CA2 132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.